Senior Research and Development Executive with demonstrated experience in leading the development and execution of drug safety and pharmacovigilance strategies while continuously driving cost-effectiveness and process optimizations. Expertise in spearheading drug development and Phase I-IV trials. Proven track record in pioneering groundbreaking first-in-class treatments. Strong background in safety science, risk mitigation, benefit-risk assessment and product development. Built and maintained positive relationships with clients and stakeholders at all levels. Developed and led highly productive teams.